C. difficile - PowerPoint PPT Presentation


New Drugs and Edits in MO HealthNet Pharmacy Program Advisory Committee Meeting - April 2023

The MO HealthNet Pharmacy Program Advisory Committee Meeting in April 2023 discusses new drugs and clinical/fiscal edits. Notable introductions include Etranacogene Dezaparvovec-drlb for Hemophilia B, Noxafil for prophylaxis of fungal infections, and Tzield for delaying Stage 3 type 1 diabetes onset

0 views • 11 slides


Infection Control and Hand Hygiene Guidelines in Healthcare Settings

Learn about Standard Precautions focusing on hand hygiene to prevent the spread of communicable diseases like Norovirus, MRSA, Influenza, E. coli, and C. difficile. Understand the importance of proper hand hygiene practices in healthcare facilities, such as washing hands with soap and water, using h

0 views • 8 slides



Management of C. difficile Infection Testing and Treatment Protocol

Stony Brook has implemented a two-step testing algorithm for C. difficile infection using PCR and EIA tests to differentiate between active infection and asymptomatic carriage. Positive PCR results are further tested with EIA. The protocol includes criteria for CDI testing, specimen collection guide

0 views • 5 slides


Understanding the Epidemic of C. Difficile Infection: Insights and Implications

C. Difficile infection is a growing concern, with a significant impact on public health in the United States. High rates of infection and mortality, particularly among the elderly, highlight the urgent need for effective prevention and management strategies. The burden of C. Difficile infection exte

0 views • 59 slides


Antibiotic Prescribing Impact on Clostridium Difficile Risk in Patients on Protein Pump Inhibitors

Antibiotic prescribing in patients on protein pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile infection. A review was conducted on high-risk antibiotic prescriptions, revealing instances where patients were prescribed against guidelines, leading to potential comp

0 views • 5 slides


Healthcare Safety Network Data & Analysis - Nevada HAI Task Force

This comprehensive dataset analysis conducted by the Nevada HAI Task Force provides insights into various healthcare-associated infections, including Catheter-Associated UTIs and C. difficile infections. The data comparison across different quarters offers valuable information for improving healthca

0 views • 8 slides


Understanding Chain of Infection and Preventing Hospital-acquired Infections

Exploring the chain of infection in communicable diseases and the role of radiologic technologists in preventing transmission. Discusses hospital-acquired infections, focusing on Clostridium difficile, and highlights the importance of breaking the chain to safeguard patient health in healthcare sett

0 views • 44 slides


Understanding Special Pathogens for Infection Prevention and Control

Pathogens such as Mycobacterium tuberculosis, Clostridium difficile, and antibiotic-resistant organisms like MRSA and VRE pose significant challenges to infection prevention programs. This content discusses the impact of these pathogens, transmission of tuberculosis, and clinical forms of TB. Antibi

0 views • 51 slides